• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个用于合理设计和挑战新型活性化合物的独特肽脱甲酰基酶平台。

A unique peptide deformylase platform to rationally design and challenge novel active compounds.

作者信息

Fieulaine Sonia, Alves de Sousa Rodolphe, Maigre Laure, Hamiche Karim, Alimi Mickael, Bolla Jean-Michel, Taleb Abbass, Denis Alexis, Pagès Jean-Marie, Artaud Isabelle, Meinnel Thierry, Giglione Carmela

机构信息

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198 Gif-sur-Yvette cedex, France.

UMR8601, LCBPT, CNRS Université Paris Descartes, PRES Paris Cité, 45 rue des Sts Pères 75270 Paris Cedex 06, France.

出版信息

Sci Rep. 2016 Oct 20;6:35429. doi: 10.1038/srep35429.

DOI:10.1038/srep35429
PMID:27762275
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5071857/
Abstract

Peptide deformylase (PDF) is considered an excellent target to develop antibiotics. We have performed an extensive characterization of a new PDF from the pathogen Streptococcus agalactiae, showing properties similar to other known PDFs. S. agalactiae PDF could be used as PDF prototype as it allowed to get complete sets of 3-dimensional, biophysical and kinetic data with virtually any inhibitor compound. Structure-activity relationship analysis with this single reference system allowed us to reveal distinct binding modes for different PDF inhibitors and the key role of a hydrogen bond in potentiating the interaction between ligand and target. We propose this protein as an irreplaceable tool, allowing easy and relevant fine comparisons between series, to design, challenge and validate novel series of inhibitors. As proof-of-concept, we report here the design and synthesis of effective specific bacterial PDF inhibitors of an oxadiazole series with potent antimicrobial activity against a multidrug resistant clinical isolate.

摘要

肽脱甲酰基酶(PDF)被认为是开发抗生素的一个理想靶点。我们对来自病原体无乳链球菌的一种新型PDF进行了广泛表征,结果表明其性质与其他已知的PDF相似。无乳链球菌PDF可作为PDF原型,因为它能够与几乎任何抑制剂化合物一起获得完整的三维、生物物理和动力学数据集。利用这个单一参考系统进行构效关系分析,使我们能够揭示不同PDF抑制剂的独特结合模式以及氢键在增强配体与靶点相互作用中的关键作用。我们提出这种蛋白质是一种不可替代的工具,它能够轻松且相关地对系列进行精细比较,以设计、挑战和验证新型抑制剂系列。作为概念验证,我们在此报告了一种恶二唑系列有效特异性细菌PDF抑制剂的设计与合成,该抑制剂对一种耐多药临床分离株具有强效抗菌活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/8ccfdc06c1f6/srep35429-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/6a32e542c62a/srep35429-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/7623c5049a70/srep35429-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/ffdc0486b11e/srep35429-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/8ccfdc06c1f6/srep35429-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/6a32e542c62a/srep35429-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/7623c5049a70/srep35429-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/ffdc0486b11e/srep35429-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1976/5071857/8ccfdc06c1f6/srep35429-f4.jpg

相似文献

1
A unique peptide deformylase platform to rationally design and challenge novel active compounds.一个用于合理设计和挑战新型活性化合物的独特肽脱甲酰基酶平台。
Sci Rep. 2016 Oct 20;6:35429. doi: 10.1038/srep35429.
2
Peptide deformylases from Vibrio parahaemolyticus phage and bacteria display similar deformylase activity and inhibitor binding clefts.副溶血弧菌噬菌体和细菌的肽脱甲酰酶显示出相似的脱甲酰酶活性和抑制剂结合裂隙。
Biochim Biophys Acta Proteins Proteom. 2018 Feb;1866(2):348-355. doi: 10.1016/j.bbapap.2017.10.007. Epub 2017 Oct 31.
3
The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.肽脱甲酰基酶作为一个靶点的演变:生物化学、遗传学和基因组学的贡献。
Biochem Pharmacol. 2006 Mar 30;71(7):1042-7. doi: 10.1016/j.bcp.2005.10.015. Epub 2005 Nov 11.
4
Characterization of a human peptide deformylase: implications for antibacterial drug design.一种人肽脱甲酰基酶的特性:对抗菌药物设计的启示。
Biochemistry. 2003 Aug 26;42(33):9952-8. doi: 10.1021/bi0346446.
5
Bacterial Peptide Deformylase Inhibition of Tetrazole-Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study.四唑取代联芳基酸类似物对细菌肽脱甲酰基酶的抑制作用:合成、生物学评价及分子对接研究
Arch Pharm (Weinheim). 2016 Dec;349(12):934-943. doi: 10.1002/ardp.201600254. Epub 2016 Nov 16.
6
Novel approaches to antimicrobial therapy: peptide deformylase.抗菌治疗的新方法:肽脱甲酰基酶
Curr Opin Drug Discov Devel. 2002 Sep;5(5):785-92.
7
Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.流感嗜血杆菌、金黄色葡萄球菌、化脓性链球菌和肺炎链球菌对肽脱甲酰基酶抑制剂GSK1322322自发耐药的频率
Antimicrob Agents Chemother. 2015 Aug;59(8):4644-52. doi: 10.1128/AAC.00484-15. Epub 2015 May 26.
8
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.新型强效肽脱甲酰基酶抑制剂——甲酰基羟氨基衍生物的合成、抗菌活性及生物学评价:针对耐药菌
Eur J Med Chem. 2014 Oct 30;86:133-52. doi: 10.1016/j.ejmech.2014.07.106. Epub 2014 Aug 12.
9
Peptide deformylase inhibitors as potent antimycobacterial agents.肽脱甲酰基酶抑制剂作为强效抗分枝杆菌剂
Antimicrob Agents Chemother. 2006 Nov;50(11):3665-73. doi: 10.1128/AAC.00555-06. Epub 2006 Sep 11.
10
Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.LBM415(NVP PDF - 713)的抗菌特性比较,一种具有临床重要性的新型肽脱甲酰基酶抑制剂。
Antimicrob Agents Chemother. 2005 Apr;49(4):1468-76. doi: 10.1128/AAC.49.4.1468-1476.2005.

引用本文的文献

1
Structures of Legionella pneumophila serogroup 1 peptide deformylase bound to nickel(II) and actinonin.嗜肺军团菌1血清型肽脱甲酰酶与镍(II)和放线菌素结合的结构
Acta Crystallogr F Struct Biol Commun. 2025 Apr 1;81(Pt 4):163-170. doi: 10.1107/S2053230X25001876. Epub 2025 Mar 17.
2
Inhibitory role of copper and silver nanocomposite on important bacterial and fungal pathogens in rice (Oryza sativa).铜银纳米复合材料对水稻重要细菌和真菌病原体的抑制作用。
Sci Rep. 2024 Jan 20;14(1):1779. doi: 10.1038/s41598-023-49918-0.
3
Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics.

本文引用的文献

1
Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.外膜和孔蛋白在产β-内酰胺酶肠杆菌科细菌对头孢他啶-阿维巴坦敏感性中的作用
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1349-59. doi: 10.1128/AAC.01585-15.
2
Access to effective antimicrobials: a worldwide challenge.获取有效的抗菌药物:全球性挑战。
Lancet. 2016 Jan 9;387(10014):168-75. doi: 10.1016/S0140-6736(15)00474-2. Epub 2015 Nov 18.
3
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
使用基于生理学的药代动力学预测IDP - 73152在人体内的药代动力学
Pharmaceutics. 2022 May 28;14(6):1157. doi: 10.3390/pharmaceutics14061157.
4
Metal utilization in genome-reduced bacteria: Do human mycoplasmas rely on iron?基因组简化细菌中的金属利用:人型支原体是否依赖铁?
Comput Struct Biotechnol J. 2021 Oct 18;19:5752-5761. doi: 10.1016/j.csbj.2021.10.022. eCollection 2021.
5
Data on molecular docking of naturally occurring flavonoids with biologically important targets.天然黄酮类化合物与具有生物学重要意义的靶点的分子对接数据。
Data Brief. 2020 Feb 4;29:105243. doi: 10.1016/j.dib.2020.105243. eCollection 2020 Apr.
6
Total synthesis of (±)-fumimycin and analogues for biological evaluation as peptide deformylase inhibitors.(±)-烟曲霉素及其类似物的全合成,用于作为肽脱甲酰基酶抑制剂的生物学评价。
Tetrahedron. 2019 Jun 14;75(24):3216-3230. doi: 10.1016/j.tet.2019.03.037. Epub 2019 Mar 27.
7
Discovery of Potential Plant-Derived Peptide Deformylase (PDF) Inhibitors for Multidrug-Resistant Bacteria Using Computational Studies.利用计算研究发现潜在的植物源肽脱甲酰基酶(PDF)抑制剂用于多药耐药细菌
J Clin Med. 2018 Dec 17;7(12):563. doi: 10.3390/jcm7120563.
8
The C-terminal residue of phage Vp16 PDF, the smallest peptide deformylase, acts as an offset element locking the active conformation.噬菌体 Vp16 PDF 的 C 末端残基是最小的肽脱甲酰酶,作为一个补偿元件锁定了活性构象。
Sci Rep. 2017 Sep 8;7(1):11041. doi: 10.1038/s41598-017-11329-3.
抗生素耐药性破解者:再利用药物能否填补抗生素发现的空白?
Nat Rev Drug Discov. 2015 Dec;14(12):821-32. doi: 10.1038/nrd4675. Epub 2015 Oct 23.
4
ESKAPEing the labyrinth of antibacterial discovery.逃出抗菌药物发现的迷宫。
Nat Rev Drug Discov. 2015 Aug;14(8):529-42. doi: 10.1038/nrd4572. Epub 2015 Jul 3.
5
Tackling antibiotic resistance: the environmental framework.应对抗生素耐药性:环境框架。
Nat Rev Microbiol. 2015 May;13(5):310-7. doi: 10.1038/nrmicro3439. Epub 2015 Mar 30.
6
N-terminal protein modifications: Bringing back into play the ribosome.蛋白质N端修饰:让核糖体重新发挥作用
Biochimie. 2015 Jul;114:134-46. doi: 10.1016/j.biochi.2014.11.008. Epub 2014 Nov 18.
7
New peptides with metal binding abilities and their use as drug carriers.具有金属结合能力的新型肽及其作为药物载体的用途。
Bioconjug Chem. 2014 Oct 15;25(10):1811-9. doi: 10.1021/bc500317u. Epub 2014 Sep 17.
8
Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery.肽脱甲酰基酶:抗菌、抗疟和抗癌药物研发的新靶点。
Curr Med Chem. 2015;22(2):214-36. doi: 10.2174/0929867321666140826115734.
9
Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart.通过揭示决定人类对应物低活性的因素来理解原核生物肽脱甲酰基酶的高效催化作用。
Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):242-52. doi: 10.1107/S1399004713026461. Epub 2014 Jan 17.
10
MRSA infections: from classical treatment to suicide drugs.耐甲氧西林金黄色葡萄球菌感染:从经典治疗到自杀药物。
Curr Med Chem. 2014;21(15):1809-19. doi: 10.2174/0929867320666131119122520.